Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues, net
Cost of products sold
Gross profit
Operating expenses:
Selling, general and administrative	1,149,257	585,502
Research and development expense	14,236	152,667
Total operating expenses	1,163,493	738,169
Loss from operations	(1,163,493)	(738,169)
Other income (expense):
Gain on issuance of Forte license	3,165,151
Interest expense	(120,403)	(210,919)
Receipt of common shares		5,761,500
Change in market value of common shares	(2,645,000)	(3,116,500)
(Loss) gain on settlement of obligations and conversion of debt	(1,166,418)	711,892
Gain on derivative liability valuation		1,178,230
Charge from warrant modification and debt settlement	(1,605,913)
Total other income (expense)	(2,372,583)	4,324,203
Net (loss) income	$ (3,536,076)	$ 3,586,034
Basic earnings (loss) per share attributed to common stockholders	$ (0.10)	$ 7.43
Diluted earnings (loss) per share attributed to common stockholders	$ (0.10)	$ 0.38
Basic weighted average number of shares outstanding	36,290,359	482,826
Diluted weighted average number of shares outstanding	36,290,359	9,394,164